Gilead Sciences, Inc.
Metabolites of bictegravir

Last updated:

Abstract:

The present invention provides metabolites of the antiviral drug bictegravir, including compositions and salts thereof, which are useful in the prevention and/or treatment of HIV as well as analytical methods related to the administration of bictegravir.

Status:
Grant
Type:

Utility

Filling date:

18 Jan 2019

Issue date:

22 Feb 2022